The Dreamboat has been touted as a more efficient delivery system than the Medtone. Therefore it is reasonable to assume that the concentraion of Afrezza is greater when using the Dreamboat. Therefore it's likely to assume that if the Afrezza is an irritant it would be more noticeable in the Dreamboat which it was.
Why wouldn't they do the same with Afrezza?
Looking forward to finding out how much "X" is. :)
Exciting week ahead for Amarantus Bioscience - AMBS.
Currently working with Becton Dickinson to develop its diagnostic test, LymPro, to detect early stage Alzheimer's. The company's patented drug, MANF, already has two orphan indications: one for Retinitis Pigmentosa and another one in the field of diabetes. A third undisclosed one was announced last week.
Currently trading under a dime. Buy and hold for six months.
read the recent Yahoo news.
You have to admit that Cramer has a better track record on his Afrezza predictions than Al has.
Cramer pontificates again.
"AMBS" - Partnership with Becton Dickinson expected soon. Under a dime. Due diligence.
Uplisting to the NASDAQ this year.
Twitter: @AmarantusBio .... 8,450 followers.